Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A machine learning model of response to hypomethylating agents in myelodysplastic syndromes.
Radakovich N, Sallman DA, Buckstein R, Brunner A, Dezern A, Mukerjee S, Komrokji R, Al-Ali N, Shreve J, Rouphail Y, Parmentier A, Mamedov A, Siddiqui M, Guan Y, Kuzmanovic T, Hasipek M, Jha B, Maciejewski JP, Sekeres MA, Nazha A. Radakovich N, et al. Among authors: shreve j. iScience. 2022 Aug 12;25(10):104931. doi: 10.1016/j.isci.2022.104931. eCollection 2022 Oct 21. iScience. 2022. PMID: 36157589 Free PMC article.
A geno-clinical decision model for the diagnosis of myelodysplastic syndromes.
Radakovich N, Meggendorfer M, Malcovati L, Hilton CB, Sekeres MA, Shreve J, Rouphail Y, Walter W, Hutter S, Galli A, Pozzi S, Elena C, Padron E, Savona MR, Gerds AT, Mukherjee S, Nagata Y, Komrokji RS, Jha BK, Haferlach C, Maciejewski JP, Haferlach T, Nazha A. Radakovich N, et al. Among authors: shreve j. Blood Adv. 2021 Nov 9;5(21):4361-4369. doi: 10.1182/bloodadvances.2021004755. Blood Adv. 2021. PMID: 34592765 Free PMC article.
Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes.
Nazha A, Komrokji R, Meggendorfer M, Jia X, Radakovich N, Shreve J, Hilton CB, Nagata Y, Hamilton BK, Mukherjee S, Al Ali N, Walter W, Hutter S, Padron E, Sallman D, Kuzmanovic T, Kerr C, Adema V, Steensma DP, Dezern A, Roboz G, Garcia-Manero G, Erba H, Haferlach C, Maciejewski JP, Haferlach T, Sekeres MA. Nazha A, et al. Among authors: shreve j. J Clin Oncol. 2021 Nov 20;39(33):3737-3746. doi: 10.1200/JCO.20.02810. Epub 2021 Aug 18. J Clin Oncol. 2021. PMID: 34406850 Free PMC article.
Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia.
Awada H, Durmaz A, Gurnari C, Kishtagari A, Meggendorfer M, Kerr CM, Kuzmanovic T, Durrani J, Shreve J, Nagata Y, Radivoyevitch T, Advani AS, Ravandi F, Carraway HE, Nazha A, Haferlach C, Saunthararajah Y, Scott J, Visconte V, Kantarjian H, Kadia T, Sekeres MA, Haferlach T, Maciejewski JP. Awada H, et al. Among authors: shreve j. Blood. 2021 Nov 11;138(19):1885-1895. doi: 10.1182/blood.2020010603. Blood. 2021. PMID: 34075412 Free PMC article.
Personalized Prediction of Hospital Mortality in COVID-19-Positive Patients.
Rozenbaum D, Shreve J, Radakovich N, Duggal A, Jehi L, Nazha A. Rozenbaum D, et al. Among authors: shreve j. Mayo Clin Proc Innov Qual Outcomes. 2021 Aug;5(4):795-801. doi: 10.1016/j.mayocpiqo.2021.05.001. Epub 2021 May 12. Mayo Clin Proc Innov Qual Outcomes. 2021. PMID: 34002167 Free PMC article.
35 results